Výsledky vyhľadávania - "lower treatment costs"
-
1
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
2
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
3
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
Dostupnosť: https://doi.org/10.1371/journal.pone.0328803.t003
https://figshare.com/articles/dataset/Costs_effectiveness_and_incremental_cost-effectiveness_of_true_cases_of_CIN2_detected_among_a_cohort_of_2_959_participants_who_received_primary_hrHPV_screening_followed_by_three_triage_strategies_among_1_269_participants_who_screened_positi/30078435 -
4
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
5
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
6
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
7
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
8
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
Dostupnosť: https://doi.org/10.1371/journal.pone.0328803.t003
https://figshare.com/articles/dataset/Costs_effectiveness_and_incremental_cost-effectiveness_of_true_cases_of_CIN2_detected_among_a_cohort_of_2_959_participants_who_received_primary_hrHPV_screening_followed_by_three_triage_strategies_among_1_269_participants_who_screened_positi/30078435 -
9
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
-
10
Autori: a ďalší
Predmety: Medicine, Biotechnology, Sociology, Cancer, Science Policy, Biological Sciences not elsewhere classified, type genotype restriction, risk human papillomavirus, prospective cohort study, inform future studies, genotyping remained dominant, cervical intraepithelial neoplasia, cervical cancer screening, burdened countries due, became less favorable, treatment costs increased, lower treatment costs, incurred additional costs, implementation costs associated, hrhpv screening combined, prospective cost analysis, cin2 +) identified, botswana , hpv triage strategies, term costs, overall costs, costs divided, triage methods, hrhpv ), without hiv
Nájsť tento článok vo Web of Science